Skip to main content

Relpax Side Effects

Generic name: eletriptan

Medically reviewed by Drugs.com. Last updated on Oct 30, 2023.

Note: This document provides detailed information about Relpax Side Effects associated with eletriptan. Some dosage forms listed on this page may not apply specifically to the brand name Relpax.

Applies to eletriptan: oral tablet.

Common side effects of Relpax

Some side effects of eletriptan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • lack or loss of strength
  • sleepiness or unusual drowsiness

Less common

  • acid or sour stomach
  • belching
  • burning, crawling, itching, numbness, prickling, “pins and needles”, or tingling feelings
  • dry mouth
  • heartburn
  • indigestion
  • stomach soreness or discomfort
  • stomach upset

Serious side effects of Relpax

Along with its needed effects, eletriptan (the active ingredient contained in Relpax) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking eletriptan:

Less common

  • chest pain or tightness
  • difficulty with swallowing
  • tightness in the throat

Rare

  • chest discomfort
  • dizziness
  • headache
  • nausea
  • nosebleeds
  • numbness or tingling in the face, arms or legs
  • pain or discomfort in the arms, jaw, back or neck
  • sweating
  • vision problems
  • vomiting

Incidence not known

  • abdominal or stomach pain
  • agitation
  • bloody diarrhea
  • confusion
  • cough
  • diarrhea
  • difficulty in speaking
  • fainting
  • fast, slow, pounding, or irregular heartbeat or pulse
  • fever
  • inability to move arms, legs, or facial muscles
  • overactive reflexes
  • pain in the arms legs, or lower back, especially pain in calves or heels upon exertion
  • pale, bluish-colored, or cold hands or feet
  • paleness or cold feeling in fingertips and toes
  • poor coordination
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • restlessness
  • seizures
  • severe or sudden headache
  • shivering
  • skin rash, hives, or itching
  • slurred speech
  • sudden loss of coordination
  • sweating
  • talking or acting with excitement you cannot control
  • tingling or pain in the fingers or toes when exposed to cold
  • trembling or shaking
  • twitching
  • unusual tiredness or weakness
  • weak or absent pulses in the legs
  • weakness in the arm or leg on one side of the body, sudden and severe

For healthcare professionals

Applies to eletriptan: oral tablet.

General

The most commonly reported adverse events have included asthenia, nausea, dizziness, and somnolence.[Ref]

Cardiovascular

Transient, dose-related increases in blood pressure (BP) have been observed, particularly in the elderly and among patients with renal impairment, and predominantly increases to diastolic BP. One patients with hepatic cirrhosis experienced a BP of 220/96 mmHg 5 hours after a receiving an 80 mg dose.[Ref]

Gastrointestinal

Nervous system

Hypersensitivity

Endocrine

Hematologic

Metabolic

Musculoskeletal

Respiratory

Dermatologic

Ocular

Other

Genitourinary

Psychiatric

References

1. (2003) "Product Information. Relpax (eletriptan)." Pfizer U.S. Pharmaceuticals

2. Cerner Multum, Inc. "UK Summary of Product Characteristics."

3. Cerner Multum, Inc. "Australian Product Information."

Further information

Relpax side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.